Tg Therapeutics TGTX
NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Tg Therapeutics (TGTX) Net Income Attributable to Noncontrolling Interests (2011 - 2012)

Updated

Tg Therapeutics (TGTX) recorded Income from Non-Controlling Interests of -$8.11 million in FY2012, compared with -$35,997 in FY2011.

Analysis

Tg Therapeutics (TGTX) Net Income Attributable to Noncontrolling Interests (2011 - 2012) Analysis & Trends

  • Per Business Quant data, TGTX's Income from Non-Controlling Interests was -$35,997 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.00 Mn
10 Tg Therapeutics 9.71 Bn 8.96 Bn 217.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 -247,962.00
Jun 30, 2012 -679,506.00
Mar 31, 2012 -7.14 Mn
Dec 31, 2011 -19,592.00
Sep 30, 2011 -1,510.00
Jun 30, 2011 -14,895.00
API Access

Tg Therapeutics Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=TGTX&period=max&api_key=YOUR_API_KEY